Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: The H6 twin randomized trials from the european organization for research and treatment of cancer lymphoma cooperative group

Journal of Clinical Oncology

Volumn 11, Issue 11, 1993, Pages 2258-2272

  Carde, Patrice ^a   Hagenbeek, Anton ^b   Hayat, Marcel ^b   Monconduit, Mathieu ^b   Thomas, José ^b   Burgers, Marion J V ^b   Noordijk, Evert M ^b   Tanguy, Alain ^b   Meerwaldt, Jacobus H ^b   Fur, René Le ^b   Somers, Reinier ^b   Kluin Nelemans, Hanneke C ^b   Busson, André ^b   Breed, Win P ^b   Bron, Dominique ^b   Holdrinet, Anthony ^b   Rutten, Ewald H J M ^b   Michiels, Jan J ^b   Regnier, René ^b   Debusscher, Louise ^b   Musella, Roberta ^b   Fargeot, Pierre ^b   Thyss, Antoine ^b   Cattan, Albert ^b   Rigal Huguet, Françoise ^b   Roth, Stephan ^b   Caillou, Bernard ^b   Dupouy, Noëlle ^b   Henry Amar, Michel ^b   more..

^a INSTITUT GUSTAVE ROUSSY   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DRUG MIXTURE; EARLY CANCER; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HODGKIN DISEASE; HUMAN; INTERMETHOD COMPARISON; INTRAVENOUS DRUG ADMINISTRATION; LAPAROTOMY; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VITAL CAPACITY;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; COMBINED MODALITY THERAPY; DACARBAZINE; DECISION TREES; DOXORUBICIN; FEMALE; HODGKIN DISEASE; HUMAN; LAPAROTOMY; MALE; MECHLORETHAMINE; MIDDLE AGE; NEOPLASM STAGING; PREDNISONE; PROCARBAZINE; RESEARCH DESIGN; TREATMENT OUTCOME; VINBLASTINE; VINCRISTINE;

EID: 0027428044     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1993.11.11.2258     Document Type: Article

References (25)

1. Tubiana M, Henry-Aman M, Hayat M, et al: Long-term results of the EORTC randomized study of irradiation and vinblastine in clinical stages I and II of Hodgkin's disease. Eur J Cancer 15:645-657, 1979
2. Rosenberg SA, Kaplan US: The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease: 1962-1984. Int J Radiat Oncol Biol Phys 11:5-32, 1985
3. Henry-Amar M, Aeppli DM, Anderson J, et al: Workshop statistical report. Part VIII: Prognostic study of overall survival by clinical stage, in Somers R. Henry-Amar M, Meerwaldt JH, et al (eds): Treatment Strategy in Hodgkin's Disease, Colloque INSERM, vol 196. London, England, Paris, France, Les Editions INSERM/John Libbey Eurotext, 1990, pp 311-354
4. Henry-Amar M, Aeppli DM, Anderson J, et al: Workshop statistical report. Part VII: Prognostic study of relapse-free overall survival by clinical stage, in Somers R. Henry-Amar M, Meerwaldt JH, et al (eds): Treatment Strategy in Hodgkin's Disease, Colloque INSERM, vol 196. London, England, Paris, France, Les Edilions INSERM/ John Libbey Eurotext, 1990, pp 265-310
5. Henry-Amar M, Hayat M, Meerwaldt JH, et al: Causes of death after therapy for early stage Hodgkin's disease entered on EORTC protocols. Int J Radiat Oncol Biol Phys 19:1155-1157, 1990
6. Henry-Amar M, Somers R: Survival outcome after Hodgkin's disease: A report from the International Data Base on Hodgkin's Disease. Semin Oncol 17:758-768, 1990
7. Tubiana M, Henry-Amar M, Van der Werf-Messing B, et al: A multivariate analysis of prognostic factors in early stages Hodgkin's disease. Int J Radiat Oncol Biol Phys 11:23-30, 1985
8. Tubiana M, Henry-Amar M, Carde P, et al: Toward comprehensive management tailored lo prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987. Blood 73:47-56, 1989
9. Carde P, Burgers JMV, Henry-Amar M, et al: Clinical stages I and II Hodgkin's disease: A specifically tailored therapy according to prognostic factors. J Clin Oncol 6:239-252, 1988
10. De Vila VT, Serpick AA, Carbone PP: Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med 73:891-895, 1970
11. Santoro A, Bonadonna G, Valagussa P, et al: Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: Superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy. J Clin Oncol 5:27-37, 1987
12. Carbone PP, Kaplan HS, Musshoff K, et al: Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 31:1860-1861, 1971
13. Lee CKK, Bloomfield CD, Goldman AI, et al: Prognostic significance of mediastinal involvement in Hodgkin's disease treated with curative radiotherapy. Cancer 46:2403-2409, 1980
14. Bristow MR, Lopez MB, Mason JW, et al: Efficacy and cost of cardiac monitoring in patients receiving doxorubicin. Cancer 50:32-41, 1982
15. Alexander J, Damiak N, Berger HJ, et al: Serial assessment of doxorubicin cardiotoxicity with quantitative radiotherapy angiocardiography. N Engl J Med 300:278-283, 1979
16. Vigersky RA, Chapman RM, Berenberg J, et al: Testicular dysfunction in untreated Hodgkin's disease. Am J Med 73:482-486, 1982
17. Rodary C, Com-Nougué C. Tournade MF: How to establish equivalence between treatments: A one-sided clinical trial in paediatric oncology. Stat Med 8:593-598, 1989
18. Dixon DO, McLaughlin P, Hagemeister FB, et al: Reporting outcomes in Hodgkin's disease and lymphoma. J Clin Oncol 5:1670-1672, 1987
19. Kaplan EL, Meier P: Non parametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
20. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
21. Rothman KJ, Boice JD: Epidemiologic Analysis with a Programmable Calculator. Boston, MA, Epidemiology Resources, 1982
22. Hryniuk WH: The importance of dose intensity in the outcome of chemotherapy, in De Vita VT, Hellman S, Rosenberg SA (eds): Important Advances in Oncology. Philadelphia, PA, J Lippincott. 1988, pp 121-141
23. Wartelle M, Kramar A, Jan P, et al: "PICAS". An interactive statistical database management system, in Hammond R, McCarthy JL (eds): Proceedings of the Second International Workshop on Statistical Database Management. Springfield, VA, National Technical Information Service, US Department of Commerce. 1983, pp 124-132
24. Somers R, Henry-Amar M, Carde P, et al: MOPP vs alternating 2 MOPP/2 ABVD in advanced Hodgkin's disease. Proc Am Soc Clin Oncol 7:236, 1988 (abstr)
25. Carde P, Mackintosh FR, Rosenberg SA: A dose and time response analysis of the treatment of Hodgkin's disease with MOPP chemotherapy. J Clin Oncol 1:146-153, 1983